clindamycin eql pharma hart hylki 300 mg
eql pharma ab - clindamycinum hýdróklóríð - hart hylki - 300 mg
s-ketamin pfizer stungulyf, lausn 25 mg/ml
pfizer aps - esketaminum hýdróklóríð - stungulyf, lausn - 25 mg/ml
furadantin tafla 50 mg
viatris aps - nitrofurantoinum inn - tafla - 50 mg
furadantin tafla 5 mg
viatris aps - nitrofurantoinum inn - tafla - 5 mg
baytril vet. tafla 150 mg
elanco animal health gmbh - enrofloxacinum inn - tafla - 150 mg
baytril vet. tafla 50 mg
elanco animal health gmbh - enrofloxacinum inn - tafla - 50 mg
noradrenalina normon innrennslisþykkni, lausn 1 mg/ml
laboratorios normon, s.a. - noradrenalinum tartrat (norepinephrinum tartrat) - innrennslisþykkni, lausn - 1 mg/ml
biorphen stungulyf, lausn 10 mg/ml
sintetica gmbh - phenylephrinum hýdróklóríð - stungulyf, lausn - 10 mg/ml
biorphen stungulyf/innrennslislyf, lausn 0,1 mg/ml
sintetica gmbh - phenylephrinum hýdróklóríð - stungulyf/innrennslislyf, lausn - 0,1 mg/ml
wakix
bioprojet pharma - pitolisant - narcolepsy - Önnur lyf í taugakerfinu - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.